Back to news list

Related News

PRESS RELEASE: EORTC and ESTRO announce E2-RADIatE platform’s first site activation for Oligometastatic Disease

31 Jul 2019

EORTC at ISCB 40, Annual Conference of the International Society for Clinical Biostatistics

11 Jul 2019

Defining the best treatment for locally advanced cervical cancer

3 Jun 2019

PRESS RELEASE: EORTC and ESTRO announce E2-RADIatE platform’s first site activation for Oligometastatic Disease

31 Jul 2019

EORTC at ISCB 40, Annual Conference of the International Society for Clinical Biostatistics

11 Jul 2019

Assessment of a potential new treatment option for patients with metastatic gastrointestinal stromal tumor (GIST) that may overcome resistance to established compounds

3 Jun 2019

PRESS RELEASE: EORTC and ESTRO announce E2-RADIatE platform’s first site activation for Oligometastatic Disease

31 Jul 2019

EORTC at ISCB 40, Annual Conference of the International Society for Clinical Biostatistics

11 Jul 2019

Defining the best treatment for locally advanced cervical cancer

3 Jun 2019